Pharmaceutical formulations, manufacturing, and related medical services in India.
Annual revenue $108 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Cronus Biotech

Cronus Biotech is a company. Cronus Biotech offers products and services including CROXITE-500 and CROGEST-200 CAP.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Cronus Biotech Ltd
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $107.54 (USD)
    214.32
    as on Mar 31, 2022
  • Net Profit
    -$4.72 K (USD)
    79.62
    as on Mar 31, 2022
  • EBITDA
    -$3.23 K (USD)
    83.75
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cronus Biotech

Cronus Biotech offers a comprehensive portfolio of products and services, including CROXITE-500 and CROGEST-200 CAP.

Product name locked
Category locked
Primary

This molecule is utilized in formulations for various medical applications, as part of the company's extensive product range.

Product name locked
Category locked
Locked

This product is employed in pharmaceutical treatments, contributing to the company's portfolio of over 200 molecules.

Funding Insights of Cronus Biotech

Premium access

Detailed funding history for Cronus Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cronus Biotech

Investments
Premium access

Investment portfolio details for Cronus Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cronus Biotech

Premium access

Detailed financials for Cronus Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cronus Biotech Comparisons

Cronus Biotech Primary company
Description
Pharmaceutical formulations, manufacturing, and related medi...
Location
-
Founded Year
-
Annual Revenue
$107.54 (USD)
Net Profit
-$4.72 K (USD)
EBITDA
-$3.23 K (USD)
Employees
Not available
Premium access

Peer comparison for Cronus Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cronus Biotech

Premium access

Detailed competitors of Cronus Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cronus Biotech

Premium access

Complete news archive for Cronus Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cronus Biotech

Annual revenue of Cronus Biotech is $107.54 as on Mar 31, 2022.

Cronus Biotech is recognized as one of the fastest growing pharmaceutical companies in India, with its headquarters located in Ahmedabad, Gujarat. A strong emphasis is placed on social responsibility, where efforts are directed towards addressing societal health concerns beyond commercial objectives. The company is noted for its ISO 9001-2008 certification and compliance with WHO-GMP standards, alongside a portfolio exceeding 200 molecules. Operations extend to formulations, third-party manufacturing, and exports to South Asian nations, while collaborations involve developing new technologies and supporting medical services through affiliated organizations.

Cronus Biotech offers CROXITE-500 and CROGEST-200 CAP.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available